AAAAAA
Results:
1-19
|
Results: 19
Authors:
Angelillo-Scherrer, A
de Frutos, PG
Aparicio, C
Melis, E
Savi, P
Lupu, F
Arnout, J
Dewerchin, M
Hoylaerts, MF
Herbert, M
Collen, D
Dahlback, B
Carmeliet, P
Citation: A. Angelillo-scherrer et al., Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis, NAT MED, 7(2), 2001, pp. 215-221
Authors:
Nemmar, A
Vanbilloen, H
Hoylaerts, MF
Hoet, PHM
Verbruggen, A
Nemery, B
Citation: A. Nemmar et al., Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster, AM J R CRIT, 164(9), 2001, pp. 1665-1668
Authors:
Oury, C
Toth-Zsamboki, E
Thys, C
Tytgat, J
Vermylen, J
Hoylaerts, MF
Citation: C. Oury et al., The ATP-gated P2X(1) ion channel acts as a positive regulator of platelet responses to collagen, THROMB HAEM, 86(5), 2001, pp. 1264-1271
Authors:
Toth-Zsamboki, E
Oury, C
Tytgat, J
Vermylen, J
Hoylaerts, MF
Citation: E. Toth-zsamboki et al., The P2Y(1) receptor antagonist adenosine-2 ',5 '-diphosphate non-selectively antagonizes the platelet P2X(1) ion channel, THROMB HAEM, 86(5), 2001, pp. 1338-1339
Authors:
Freson, K
Hoylaerts, MF
Jaeken, J
Eyssen, M
Arnout, J
Vermylen, J
Van Geet, C
Citation: K. Freson et al., Genetic variation of the extra-large stimulatory G protein alpha-subunit leads to Gs hyperfunction in platelets and is a risk factor for bleeding, THROMB HAEM, 86(3), 2001, pp. 733-738
Authors:
Van Geet, C
Jaeken, J
Freson, K
Lenaerts, T
Arnout, J
Vermylen, J
Hoylaerts, MF
Citation: C. Van Geet et al., Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications, J INH MET D, 24(4), 2001, pp. 477-492
Authors:
Ngo, TH
Hoylaerts, MF
Knockaert, I
Brouwers, E
Declerck, PJ
Citation: Th. Ngo et al., Identification of a target site in plasminogen activator inhibitor-1 that allows neutralization of its inhibitory properties concomitant with an allosteric up-regulation of its antiadhesive properties, J BIOL CHEM, 276(28), 2001, pp. 26243-26248
Authors:
Kawasaki, T
Dewerchin, H
Lijnen, HR
Vreys, I
Vermylen, J
Hoylaerts, MF
Citation: T. Kawasaki et al., Mouse carotid artery ligation induces platelet-leukocyte-dependent luminalfibrin, required for neointima development, CIRCUL RES, 88(2), 2001, pp. 159-166
Authors:
Freson, K
Devriendt, K
Matthijs, G
Van Hoof, A
De Vos, R
Thys, C
Minner, K
Hoylaerts, MF
Vermylen, J
Van Geet, C
Citation: K. Freson et al., Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation, BLOOD, 98(1), 2001, pp. 85-92
Authors:
Hoylaerts, MF
Oury, C
Toth-Zsamboki, E
Vermylen, J
Citation: Mf. Hoylaerts et al., ADP receptors in platelet activation and aggregation, PLATELETS, 11(6), 2000, pp. 307-309
Authors:
Cauwenberghs, N
Ajzenberg, N
Vauterin, S
Hoylaerts, MF
Declerck, PJ
Baruch, D
Deckmyn, H
Citation: N. Cauwenberghs et al., Characterization of murine anti-glycoprotein ib monoclonal antibodies thatdifferentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand Factor interaction, HAEMOSTASIS, 30(3), 2000, pp. 139-148
Authors:
Oury, C
Toth-Zsamboki, E
Van Geet, C
Thys, C
Wei, L
Nilius, B
Vermylen, J
Hoylaerts, MF
Citation: C. Oury et al., A natural dominant negative P2X1 receptor due to deletion of a single amino acid residue, J BIOL CHEM, 275(30), 2000, pp. 22611-22614
Authors:
Arza, B
Hoylaerts, MF
Felez, J
Collen, D
Lijnen, HR
Citation: B. Arza et al., Prostromelysin-1 (proMMP-3) stimulates plasminogen activation by tissue-type plasminogen activator, EUR J BIOCH, 267(21), 2000, pp. 6378-6384
Authors:
Kawasaki, T
Dewerchin, M
Lijnen, HR
Vermylen, J
Hoylaerts, MF
Citation: T. Kawasaki et al., Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysisduring acute arterial thrombosis in mice, BLOOD, 96(1), 2000, pp. 153-160
Authors:
De Meyer, GRY
Hoylaerts, MF
Kockx, MM
Yamamoto, H
Herman, AG
Bult, H
Citation: Gry. De Meyer et al., Intimal deposition of functional von Willebrand factor in atherogenesis, ART THROM V, 19(10), 1999, pp. 2524-2534
Authors:
Wynendaele, W
Derua, R
Hoylaerts, MF
Pawinski, A
Waelkens, E
de Bruijn, EA
Paridaens, R
Merlevede, W
van Oosterom, AT
Citation: W. Wynendaele et al., Vascular endothelial growth factor measured in platelet poor plasma allowsoptimal separation between cancer patients and volunteers: A key to study an angiogenic marker in vivo?, ANN ONCOL, 10(8), 1999, pp. 965-971
Authors:
Kawasaki, T
Kaida, T
Arnout, J
Vermylen, J
Hoylaerts, MF
Citation: T. Kawasaki et al., A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic, THROMB HAEM, 81(2), 1999, pp. 306-311
Authors:
Theilmeier, G
Lenaerts, T
Remacle, C
Collen, D
Vermylen, J
Hoylaerts, MF
Citation: G. Theilmeier et al., Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stress, BLOOD, 94(8), 1999, pp. 2725-2734
Authors:
Peerlinck, K
Jacquemin, MG
Arnout, J
Hoylaerts, MF
Gilles, JGG
Lavend'homme, R
Johnson, KM
Freson, K
Scandella, D
Saint-Remy, JMR
Vermylen, J
Citation: K. Peerlinck et al., Antifactor VIII antibody inhibiting allogeneic but not antologous factor VIII in patients with mild hemophilia A, BLOOD, 93(7), 1999, pp. 2267-2273
Risultati:
1-19
|